326 related articles for article (PubMed ID: 16963215)
1. Cannabinoid concentrations in hair from documented cannabis users.
Huestis MA; Gustafson RA; Moolchan ET; Barnes A; Bourland JA; Sweeney SA; Hayes EF; Carpenter PM; Smith ML
Forensic Sci Int; 2007 Jul; 169(2-3):129-36. PubMed ID: 16963215
[TBL] [Abstract][Full Text] [Related]
2. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
[TBL] [Abstract][Full Text] [Related]
3. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ
J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389
[TBL] [Abstract][Full Text] [Related]
4. Interpretation of Cannabis Findings in the Hair of Very Young Children: Mission Impossible.
Kintz P; Ameline A; Eibel A; Gheddar L; Feisthauer E; Geraut A; Berthelon L; Farrugia A; Raul JS
Curr Pharm Biotechnol; 2017; 18(10):791-795. PubMed ID: 29189142
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration.
Milman G; Barnes AJ; Schwope DM; Schwilke EW; Goodwin RS; Kelly DL; Gorelick DA; Huestis MA
Anal Bioanal Chem; 2011 Aug; 401(2):599-607. PubMed ID: 21637933
[TBL] [Abstract][Full Text] [Related]
6. Hair analysis for Delta9-tetrahydrocannabinolic acid A--new insights into the mechanism of drug incorporation of cannabinoids into hair.
Auwärter V; Wohlfarth A; Traber J; Thieme D; Weinmann W
Forensic Sci Int; 2010 Mar; 196(1-3):10-3. PubMed ID: 20129747
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy Adults.
Schlienz NJ; Cone EJ; Herrmann ES; Lembeck NA; Mitchell JM; Bigelow GE; Flegel R; LoDico CP; Hayes ED; Vandrey R
J Anal Toxicol; 2018 May; 42(4):232-247. PubMed ID: 29300962
[TBL] [Abstract][Full Text] [Related]
8. 11-OH-THC in hair as marker of active cannabis consumption: Estimating a reliable cut-off by evaluation of 672 THC-positive hair samples.
Casati S; Angeli I; Ravelli A; Del Fabbro M; Minoli M; Orioli M
Forensic Sci Int; 2019 Nov; 304():109951. PubMed ID: 31563559
[TBL] [Abstract][Full Text] [Related]
9. Finding cannabinoids in hair does not prove cannabis consumption.
Moosmann B; Roth N; Auwärter V
Sci Rep; 2015 Oct; 5():14906. PubMed ID: 26443501
[TBL] [Abstract][Full Text] [Related]
10. Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure.
Lowe RH; Abraham TT; Darwin WD; Herning R; Cadet JL; Huestis MA
Drug Alcohol Depend; 2009 Nov; 105(1-2):24-32. PubMed ID: 19631478
[TBL] [Abstract][Full Text] [Related]
11. Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
Lee D; Karschner EL; Milman G; Barnes AJ; Goodwin RS; Huestis MA
Drug Alcohol Depend; 2013 Jun; 130(1-3):68-76. PubMed ID: 23146820
[TBL] [Abstract][Full Text] [Related]
12. Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.
Goodwin RS; Gustafson RA; Barnes A; Nebro W; Moolchan ET; Huestis MA
Ther Drug Monit; 2006 Aug; 28(4):545-51. PubMed ID: 16885723
[TBL] [Abstract][Full Text] [Related]
13. Passive cannabis smoke exposure and oral fluid testing.
Niedbala S; Kardos K; Salamone S; Fritch D; Bronsgeest M; Cone EJ
J Anal Toxicol; 2004 Oct; 28(7):546-52. PubMed ID: 15516313
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids in hair: strategy to prove marijuana/hashish consumption.
Uhl M; Sachs H
Forensic Sci Int; 2004 Oct; 145(2-3):143-7. PubMed ID: 15451086
[TBL] [Abstract][Full Text] [Related]
15. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.
Milman G; Bergamaschi MM; Lee D; Mendu DR; Barnes AJ; Vandrey R; Huestis MA
Ther Drug Monit; 2014 Apr; 36(2):218-24. PubMed ID: 24067260
[TBL] [Abstract][Full Text] [Related]
16. Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC.
Karschner EL; Schwope DM; Schwilke EW; Goodwin RS; Kelly DL; Gorelick DA; Huestis MA
Drug Alcohol Depend; 2012 Oct; 125(3):313-9. PubMed ID: 22464363
[TBL] [Abstract][Full Text] [Related]
17. Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid.
Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
J Anal Toxicol; 2019 May; 43(4):233-258. PubMed ID: 30615181
[TBL] [Abstract][Full Text] [Related]
18. Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.
Karschner EL; Schwilke EW; Lowe RH; Darwin WD; Herning RI; Cadet JL; Huestis MA
J Anal Toxicol; 2009 Oct; 33(8):469-77. PubMed ID: 19874654
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of postmortem concentrations of Δ
Hoffman MA; Trochta A; Gary RD; Fitzgerald RL; McIntyre IM
Forensic Sci Int; 2020 Oct; 315():110414. PubMed ID: 32738674
[TBL] [Abstract][Full Text] [Related]
20. Estimating time of last oral ingestion of cannabis from plasma THC and THCCOOH concentrations.
Huestis MA; Elsohly M; Nebro W; Barnes A; Gustafson RA; Smith ML
Ther Drug Monit; 2006 Aug; 28(4):540-4. PubMed ID: 16885722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
